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ABSTRACT 
OBJECTIVE: To determine the prevalence and risk factors 
for nosocomial infections (NIs) in four Swiss university hospitals. 
DESIGN AND SETTING: A 1-week period-prevalence 
survey conducted in May 1996 in medical, surgical, and intensive-
care wards of four Swiss university hospitals (900-1,500 beds). 
Centers for Disease Control and Prevention definitions were used, 
except that asymptomatic bacteriuria was not categorized as NI. 
Study variables included patient demographics, primary diagnosis, 
comorbidities, exposure to medical and surgical risk factors, and 
use of antimicrobials. Risk factors for NIs were determined using 
logistic regression with adjustment for length of hospital stay, 
study center, device use, and patients' comorbidities. 
RESULTS: 176 NI were recorded in 156 of 1,349 screened 
patients (11.6%; interhospital range, 9.8%-13.5%). The most fre-
quent NI was surgical-site infection (53; 30%), followed by urinary 
tract infection (39; 22%), lower respiratory tract infection (27; 15%), 
and bloodstream infection (23; 13%). Prevalence of NI was higher 
in critical-care units (25%) than in medical (9%) and surgical wards 
(12%). Overall, 65% of NIs were culture-proven; the leading 
pathogens were Enterobacteriaceae (44; 28%), Staphylococcus 
aureus (20; 13%), Pseudomonas aeruginosa (17; 11%), and Candida 
species (16; 10%). Independent risk factors for NI were central 
venous catheter (CVC) use (odds ratio [OR], 3.35; 95% confidence 
interval [CI%], 2.91-3.80), admission to intensive care (OR, 1.75; 
CI95, 1.30-2.21), emergency admission (OR, 1.57; CI95, 1.15-2.00), 
impaired functional status (Karnofsky index 1-4: OR, 2.56; CI95, 
1.95-3.17), and McCabe classification of ultimately fatal (OR, 2.50; 
CI95,2.04-2.96) or rapidly fatal (OR, 2.25; CI95,1.52-2.98) underlying 
condition. 
CONCLUSIONS: According to the results of this survey, 
NIs are frequent in Swiss university hospitals. This investigation 
confirms the importance of CVCs as a major risk factor for NI. 
Patient comorbidities must be taken into account to adjust for case 
mix in any study comparing interhospital or intrahospital infection 
rates (Infect Control Hosp Epidemiol 1999;20:37-42). 
Patients admitted to the hospital are at risk of noso-
comial infection (NI). Surveillance of NIs has been widely 
accepted throughout the world as a primary step toward 
prevention of NI.12 The gold standard is a prospective, on-
site, continuous, hospitalwide surveillance; however, these 
incidence surveys require exhaustive resources. 
Therefore, prevalence studies, which are easier to perform 
and less expensive, often are conducted to provide baseline 
information about the occurrence of NI and to help estab-
lish priorities for infection control.3"5 
In Switzerland, the concept of patient-oriented sur-
veillance of NI was introduced in the 1980s as previously 
described.6 The five university hospitals in Switzerland and 
their infection control programs have been linked together 
in the Swiss Noso network since 1992. On the basis of this 
network and with the support of the Swiss Society for 
Hospital Hygiene, the first Swiss prevalence study on NIs 
was conducted in May 1996 in selected wards of four 
(Basel, Geneva, Lausanne, and Zurich) of those five teach-
ing hospitals. 
The objective of this survey was to determine the 
prevalence and risk factors of NIs at four Swiss university 
centers, after adjustment for case mix, patient comorbidi-
ties, extrinsic risk factors, length of hospital stay, and study 
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center, and to set further priorities in infection control at 
these institutions. 
METHODS 
Setting 
The four participating hospitals are tertiary health-
care centers with an average size of 1,100 beds.6 The study 
was conducted between May 20 and May 27,1996, in med-
ical, surgical, and intensive-care units (ICUs). The sur-
veyed wards, selected to provide a balance in case mix, 
included a total of 1,958 beds (average, 490 beds per hospi-
tal; range, 462-510), representing 45% (1,958/4,386) of the 
total number of hospital beds. The bed occupancy rate in 
the surveyed wards at the time of study ranged from 60% to 
81% in the different centers, with an average of 69% 
(1,349/1,958). 
Definitions 
Standard definitions by the Centers for Disease 
Control and Prevention were used, except that asympto-
matic bacteriuria was not categorized as NI.7 NI was 
defined as occurrence of infection at least 48 hours after 
hospital admission without evidence that the infection was 
present or incubating at time of admission. All patients 
readmitted within 7 days after discharge who presented at 
time of study with a documented infection were evaluated 
for a possible NI. Surgical-site infections were document-
ed as NI within 30 days after the operation, or 1 year in 
case of infection associated with insertion of a prosthetic 
device. 
Quality Control Issues and Data Collection 
Three prevalence studies performed either hospital-
wide or only in some departments were conducted previ-
ously at one of the centers (Geneva). Thus, the study pro-
tocol, case report form (CRF), database for data collection, 
double data-entry process, and methods for data analysis 
had been pretested prior to this survey. Validation of the 
observers was performed before and during the preva-
lence surveys at this center; both internal and external 
validity was excellent (kappa statistics >0.80). 
The CRF was tested at each study center in 1995 and 
further tested in April 1996. During the study, CRFs were 
reviewed at each center by the center coordinator and com-
pleted when necessary. Overall, 10% to 15% of all patients 
surveyed at the time of the study were evaluated by two 
separate independent observers who were members of 
either the infection control or the infectious diseases staff. 
Following the completion of the study, all CRFs were ren-
dered anonymous, collected centrally, and rechecked 
(S.H.). The study investigators met several times during 
and after the study to ensure validity of the data collection 
at each center and to discuss problems. A study coordina-
tor was designated for the whole study (D.P.). 
Infected patients were identified by review of nursing 
and medical charts and by information provided by physi-
cians and nurses in charge of the patients. All NIs required 
full written documentation, including microbiological data 
whenever available. This included culture results under-
taken during, or up to 1 week after, the study period. 
A specially designed database developed at the 
University Hospitals of Geneva was used for data entry 
(using ACCESS, version 2.0; Microsoft Co, Ireland) and 
double data entry was performed. 
Study Variables 
A total of 63 study variables were recorded for both 
infected and noninfected patients. Primary diagnosis was 
determined and classified according to the International 
Classification of Diseases, 9th revision.8 The 20 groups of 
diagnoses corresponded to the respective ICD-9-CM clas-
sification codes and were used as described elsewhere.9 
Patients were classified into three categories depending on 
the severity of illness according to the classification pro-
posed by McCabe and Jackson.10 Patients' comorbidities 
were recorded according to the score proposed by 
Charlson.11 Functional status was assessed by the 
Karnofsky index.12 Additional conditions associated with 
increased risk of NI were noted (HIV infection, neutrope-
nia, chemotherapy, intravenous drug abuse, and organ 
transplantation). 
External risk factors, such as indwelling devices, 
type and route of nutrition, tracheostomy, oral or nasal intu-
bation, and medication, such as antimicrobial agents (for 
therapeutic or prophylactic purposes), use of steroids, or 
ulcer prophylaxis, were documented. Time of assessment 
of major variables for infected patients was 7 days before 
the time by which the patient met the criteria for NI and 7 
days before the date of the study for noninfected patients. 
Statistical Analysis 
Two measures of the frequency of NIs were calculat-
ed: the prevalence of infections, defined as the ratio of the 
number of clinically active infections to the total number of 
patients studied (expressed as a percentage), and the 
prevalence of infected patients, defined as the percentage 
of patients with active infection in relation to the total num-
ber of patients studied. 
The combined study of the possible risk factors for 
NI was conducted by means of logistic regression models. 
Only variables associated with Pvalues <.l in the univariate 
analysis were included in the models. Explanatory vari-
ables for the outcome (NI) were: hospital ward, emergency 
admission, age, gender, length of stay at time of infection 
(infected patients) or at time of study (noninfected 
patients), Karnofsky index, McCabe classification, 
Charlson index, invasive procedures (central venous, arte-
rial, or urinary catheterization; orotracheal intubation; 
drainage), surgery, treatment with steroids, and stress-
ulcer prophylaxis. Colinearity between study variables 
included in the multiple logistic regression model was 
excluded by analysis of correlation (all correlation coeffi-
cients <0.5). Statistical analysis was performed using SPSS 
software (SPSS Inc, Chicago, IL). All reported P values 
were two-sided, and values less than .05 were considered 
statistically significant. 
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RESULTS 
General Demographics 
A total of 1,349 CRFs (one per patient) suitable for 
analysis were available: 413 patients in center A, 325 in cen-
ter B, 296 in center C, and 315 in center D. Of screened 
patients, 672 (50%) were in surgical wards, 585 (43%) in 
medical wards, and 92 (7%) in ICUs. A total of 518 patients 
(38%) had surgery prior to the study time point; 72% of 
those patients had undergone elective surgery, and 28% 
emergency surgery. A total of 662 patients (49%) were 
receiving antimicrobial agents at the time of the study. 
Prevalence, Pathogens, and Sites of Infections 
There were a total of 176 NIs in 156 patients. Thus, 
the overall prevalence of infections and infected patients 
was 13.0% and 11.6%, respectively. Among the 156 patients 
with NI, 123 (79%) had a single infection, 22 (14%) had two 
infections, and 11 (7%) had three or more. Rates of NI at the 
participating centers ranged from 9.8% to 13.5%. 
A high prevalence of NI was observed in ICUs (23 
infected patients [25%] of a total of 92 screened patients). 
Rates of infection averaged 9% (53 infected patients/total 
585 screened patients; range, 6%-15% between the study 
centers) in the medical wards, and 12% (80/672; range, 10%-
14%) in the surgical wards. 
Among the 176 episodes of NI, 157 microorganisms 
were isolated in 117 (66%) of the cases. There were 84 infec-
tions caused by a single microorganism; 33 NIs were 
polymicrobial. The proportional frequencies of leading 
pathogens isolated are summarized in Table 1. 
Among the 176 detected NIs, the most frequent type 
was surgical-site infection (53; 30%), followed by urinary 
tract infection (39; 22%); lower respiratory tract infection 
(27; 15%); bloodstream infection (23; 13%); ear, nose, and 
throat infection (11; 6%); and skin infection (7; 4%). Sixteen 
other infections accounted for an additional 9%. 
Intrinsic Risk Factors 
The median age of the 1,349 studied patients was 62 
(range, 16-100) years; 787 patients (58%) were men. 
Primary diagnoses associated with an increased preva-
lence of NI and further information concerning comorbidi-
ties (Charlson index) and functional capacity (Karnofsky 
scale) among infected and noninfected patients are shown 
in Table 2. Patients with rapidly fatal (OR, 2.46; CI95, 1.85-
3.07) or ultimately fatal (OR, 1.96; CI95, 1.56-2.35) underly-
ing illness, according to the classification by McCabe and 
Jackson, were at higher risk for NI than those suffering 
from nonfatal conditions (Table 2). 
Length of Stay and Exogenous Risk Factors 
The average length of hospital stay from admission 
to study day was 12.6 days (median, 7; range, 0-234). 
Length of stay from admission to NI averaged 15.3 days 
(median, 9; range, 0-215). For those patients who had not 
acquired NI, length of hospital stay averaged 10.2 days at 
time of study (median, 6; range, 0-196). 
Table 3 summarizes the prevalence of exogenous 
TABLE 1 
NOSOCOMIAL INFECTIONS IN SWISS TEACHING HOSPITALS: 
LEADING PATHOGENS* 
Organisms 
Staphylococcus aureus* 
Escherichia coli 
Pseudomonas aeruginosa 
Candida species 
Other Enterobacteriaceae 
Coagulase-negative staphylococci 
Enterococcus species 
Enterobacter species 
No. 
20 
19 
17 
16 
16 
14 
13 
9 
Prevalence (%) 
13 
12 
11 
10 
10 
9 
9 
6 
* A total of 157 bacterial and fungal pathogens were isolated in 117 episodes of microbiological-
ly documented infection. 
t Two of 20 Staphylococcus aureus strains were methicillin-resistant. 
risk factors for infection. By univariate analysis, surgical 
intervention; steroids; omeprazole and sucralfate; exposure 
to indwelling devices such as urinary, central venous, and 
arterial catheters; and orotracheal intubation increased the 
risk of infection (all P<.05). 
Independent Factors for Nosocomial Infection 
In the overall logistic regression model for NI, the 
following factors were independently associated with NI 
(Table 4): central venous catheterization, severity of under-
lying disease as measured by the McCabe classification, 
the degree of dependence as measured by the Karnofsky 
index (all F<.05), admission to the ICU, and emergency 
admission. 
DISCUSSION 
In a recently published point-prevalence study of NIs 
in ICUs in 14 European countries, Switzerland with its 49 
participating ICUs had one of the lowest infection rates, 
with only 9.7% of the patients having an ICU-acquired infec-
tion.3 In contrast to these somewhat controversial findings, 
our 7-day period-prevalence study found NIs in Swiss uni-
versity hospitals to be no less frequent than in neighboring 
European countries (Table 5). Our observed prevalence of 
11.6% is roughly comparable with that found in other point-
prevalence studies in teaching hospitals or medical centers 
with more than 500 beds (4.4%-14.8%).4'51316The observed 
NI rate of 25% among ICU patients clearly is within the 
reported range of NI rates in ICUs and is consistent with 
data from other countries.317 
Our study shows some additional interesting find-
ings compared to previously published work. By excluding 
asymptomatic bacteriuria as a criterion for NI, as previ-
ously proposed by the EPINE (Estudio de Prevalencia de 
las Infecciones Nosocomiales en Espaiia) study,4 the 
observed spectrum of NI shifted toward a higher propor-
tion of surgical-site (30%) and respiratory tract (15%) infec-
tions, and a lower proportion of urinary tract infections 
(22%) than reported in other studies.1416 Moreover, length 
of hospitalization was not an independent risk factor for NI 
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TABLE 2 
PATIENT CHARACTERISTICS AND INTRINSIC RISK FACTORS FOR NOSOCOMIAL INFECTION: UNIVARIATE ANALYSIS 
Infected Patients Noninfocted 
(n=156, %) Patients (n=1,193, %) OR CL 
Age,* years (mean±SD) 
<45 
45-59 
60-69 
70-79 
>80 
Gender 
Male 
Female 
Hospital location 
Medical ward 
Surgical ward 
Intensive care 
Center 
A 
B 
C 
D 
Admission condition' 
Emergency 
Elective 
Primary diagnosis' 
Cancer 
Diseases of the circulatory system 
Diseases of the digestive system 
Trauma 
Respiratory diseases and infections 
Others^ 
McCabe classification'! 
Nonfatal 
Ultimately fatal 
Rapidly fatal 
Charlson index 
0-1 
2-5 
6-12 
Karnofsky index11 
8-10 
5-7 
1-4 
60.0 
31 
41 
34 
32 
18 
89 
67 
52 
81 
23 
49 
36 
40 
31 
98 
51 
27 
40 
22 
21 
21 
25 
90 
43 
15 
77 
60 
19 
64 
62 
22 
±17.0 
(20%) 
(26%) 
(22%) 
(21%) 
(12%) 
(57%) 
(43%) 
(33%) 
(52%) 
(15%) 
(31%) 
(23%) 
(26%) 
(20%) 
(66%) 
(34%) 
(17%) 
(26%) 
(14%) 
(13%) 
(13%) 
(16%) 
(61%) 
(29%) 
(10%) 
(49%) 
(38%) 
(12%) 
(43%) 
(42%) 
(15%) 
60.4 
241 
272 
245 
266 
162 
698 
495 
533 
591 
69 
364 
289 
256 
284 
642 
513 
143 
252 
146 
137 
197 
304 
856 
209 
58 
692 
389 
112 
664 
404 
85 
±17.8 
(20%) 
(23%) 
(21%) 
(22%) 
(14%) 
(59%) 
(41%) 
(45%) 
(49%) 
(6%) 
(31%) 
(24%) 
(21%) 
(24%) 
(56%) 
(44%) 
(12%) 
(21%) 
(12%) 
(12%) 
(17%) 
(26%) 
(76%) 
(19%) 
(5%) 
(58%) 
(33%) 
(9%) 
(58%) 
(35%) 
(7%) 
Ref 
1.17 
1.07 
0.94 
0.86 
1.06 
Ref 
1.40 
3.41 
1.23 
1.14 
1.43 
Ref 
1.53 
2.30 
1.93 
1.83 
1.86 
1.30 
Ref 
Ref 
1.96 
2.46 
Ref 
1.39 
1.52 
Ref 
1.59 
2.69 
— 
0.67-1.67 
0.56-1.60 
0.41-1.46 
0.25-1.48 
0.76-1.49 
— 
1.03-1.77 
2.86-3.97 
0.76-1.71 
0.63-1.65 
0.93-1.93 
— 
1.07-2.20 
1.72-2.88 
1.40-2.46 
1.23-2.44 
1.25-2.48 
0.69-1.90 
— 
— 
1.56-2.35 
1.85-3.07 
— 
1.03-1.75 
0.98-2.06 
— 
1.22-1.96 
2.15-3.22 
Abbreviations: Cl,]5, 95% confidence interval: OR, odds ratio; Ref, reference group; SD, standard deviation. 
* Missing data in 7 patients. 
f Missing data in 45 patients. 
* Missing data in 14 patients. 
§ "Others" refers to all primary diagnosis for admission not included in the categories listed. 
|| Missing data in 78 patients, 
•fl Missing data in 48 patients. 
after adjustment for case mix, in contrast to other 
reports.4'16'18'19 
The particular strength of this study is the in-depth 
analysis of possible intrinsic and extrinsic risk factors for 
NI. After adjustment for case mix and controlling for a large 
number of potential confounding variables, we identified 
several extrinsic (use of CVC, admission to ICUs, emer-
gency admission) and intrinsic (McCabe classification; 
Karnofsky index) factors to be associated independently 
with a significantly increased risk for NI. We believe that 
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TABLE 3 
EXPOSURE TO EXOGENOUS RISK FACTORS FOR NOSOCOMIAL INFECTION IN THE TOTAL POPULATION OF 1,349 SURVEYED PATIENTS: 
UNIVARIATE ANALYSIS 
Factor 
Number (%) of Patients 
Infected Nonlnfected OR CL 
No. of patients 
Surgery prior to study 
Solid-organ transplant 
Chemotherapy 
Steroids 
Stress ulcer prophylaxis 
Ranitidine 
Omeprazole 
Sucralfate 
Exposure to indwelling devices 
Urinary catheters 
Intubation 
Central venous catheter 
Arterial catheter 
Peripheral catheter 
Permanent catheter* 
Surgical drains 
Length of stay, days* 
0-2 
3-7 
8-14 
>14 
1 
91 
2 
13 
14 
19 
87 
18 
64 
19 
74 
16 
85 
6 
30 
28 
39 
32 
51 
56 
(58) 
(1.3) 
(8.3) 
(9.0) 
(12) 
(56) 
(12) 
(41) 
(12) 
(47) 
(10) 
(55) 
(4) 
(19) 
(19) 
(26) 
(21) 
(34) 
1,193 
480 
14 
77 
55 
125 
577 
77 
297 
71 
246 
58 
753 
34 
122 
317 
363 
284 
224 
(40) 
(1.2) 
(6.5) 
(4.6) 
(10) 
(48) 
(6.5) 
(25) 
(6) 
(21) 
(5) 
(63) 
(3) 
(10) 
(27) 
(30) 
(24) 
(19) 
2.08 
1.09 
1.32 
2.04 
1.18 
1.47 
1.89 
2.10 
2.17 
3.47 
2.23 
0.70 
1.36 
2.09 
Ref.' 
1.22 
1.28 
2.58 
1.48-2.91 
0.25-4.86 
0.71-2.43 
1.10-3.76 
0.71-1.99 
1.04-2.10 
1.10-3.26 
1.48-2.96 
1.27-3.71 
2.46-4.90 
1.25-3.99 
0.50-0.98 
0.56-3.29 
1.34-3.24 
0.71-1.73 
0.80-1.75 
2.09-3.07 
Abbreviations: CI,^ , 95% confidence interval; OR, odds ratio. 
* Permanent catheter: Hickman lines and other permanently inserted catheters. 
t Missing data in 11 patients. 
t Indicates reference group. 
TABLE 4 
INDEPENDENT RISK FACTORS FOR NOSOCOMIAL INFECTION: 
STEPWISE LOGISTIC REGRESSION MODEL* 
Variable OR CL 
Extrinsic factors 
CVC 
ICU stay 
Emergency admission 
Intrinsic factors 
Karnofsky index 
5-7 
1-4 
McCabe classification 
Ultimately fatal 
Rapidly fatal 
3.35 
1.75 
1.57 
1.38 
2.56 
2.50 
2.25 
2.91-3.80 
1.30-2.21 
1.15-2.00 
0.95-1.82 
1.95-3.17 
2.04-2.96 
1.52-2.98 
.0001 
.015 
.037 
.14 
.003 
.0001 
.029 
Abbreviations: CL ,^ 95% confidence interval; CVC, central venous catheter; ICU, intensive-care 
unit; OR, odds ratio. 
* Likelihood ratio, 700.66; goodness of fit, 1117.7. Variables included were hospital ward, emer-
gency admission, age, gender, length of stay at time of infection (infected patients) or at time of 
study (noninfected patients), Karnofsky index, McCabe classification, Charlson index, invasive 
procedures (central venous, arterial, urinary catheterization, orotracheal intubation, or surgical 
drainage), surgery, treatment with steroids, and stress ulcer prophylaxis. 
TABLE 5 
PREVALENCE STUDIES OF NOSOCOMIAL INFECTION IN SEVERAL 
UNIVERSITY HOSPITALS AND TERTIARY-CARE CENTERS WITH 
MORE THAN 500 BEDS 
Country 
Belgium 
Australia 
Hong Kong 
Spain 
France 
Norway 
United Kingdom 
Lithuania 
Germany 
Switzerland 
Reference 
Unpublished data* 
13 
5 
4 
24 
14 
15 
25 
22 
Present study 
Year 
of Study 
1984 
1984 
1986 
1990 
1990 
1991 
1993 
1994 
1994 
1996 
Prevalence (%) 
14.8 
8.6 
10.5 
8.6 
9.0 
6.5 
11.2 
9.2 
4.4 
11.6 
* O. Ronveaux, MD, Institute of Public Health-Louis Pasteur, Brussels, Belgium, oral commu-
nication based on unpublished data from reference 16. 
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patient comorbidities must be taken into account to adjust 
for case mix in any study comparing interhospital or intra-
hospital infection rates or developing predictive models for 
NIs. Studies such as ours, seeking to improve the quality of 
predictive models, contribute to this substantial task. 
Furthermore, our results confirm other reports3,20,21 con-
cerning exposure to CVCs as one of the most important 
independent risk factors for infection (OR, 3.35; CI95, 2.91-
3.80). Importantly, among 23 episodes of nosocomial blood-
stream infection, we identified 8 cases (35%) associated 
with CVC infections. Thus, efforts to prevent device-
associated infections would have a major impact on intra-
hospital infection rates in the participating hospitals. 
Several limitations of this prevalence survey need to 
be considered. First, it was not performed hospitalwide 
but only in selected areas (surgical, medical, and critical-
care wards) of four university hospitals in Switzerland. 
Certainly, the prevalence would have been lower if small-
er nonteaching hospitals and more low-risk areas had 
been included, as demonstrated by the German NIDEP 
(Nosokomiale Infektionen in Deutschland Erfassung und 
Prevention) study.22 Second, results of prevalence studies 
are directly influenced by the duration of the condition 
under study. Thus, period-prevalence studies may tend to 
overestimate rates of NIs compared to point-prevalence 
surveys. However, we chose to conduct a period-prevalence 
study with a well-defined time window to identify NI bet-
ter and to assess more accurately the exposure to risk fac-
tors. Third, seasonal variations may have influenced the 
results of this survey, which was performed shortly 
before a long holiday weekend (Pentecost), explaining 
the relatively low occupancy rate and possibly resulting in 
an overestimation of the number of patients with NI. 
Finally, we did not examine the number of diagnostic tests 
performed in the different centers; thus, by decreasing or 
increasing the number of diagnostic tests, the different 
centers may have decreased or increased the number of 
observed NIs in different surveyed areas, as reported by 
Haley et al.23 A major detection bias is, however, unlikely, 
considering the absence of a significant variation in both 
infection rates and case mix across study centers. 
In summary, our study gives important information 
on the prevalence of NIs in Swiss university hospitals and 
the impact of extrinsic and intrinsic risk factors on NIs in 
these institutions. Our results should be an incentive to 
scrutinize current methods and standards of comparing 
surveillance data from different hospitals without well-
performed adjustment for case mix. 
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